Since COVID erupted, the FTC and FDA have issued hundreds of warning letters to practitioners requiring them to delete online posts about immune system support or potential COVID treatments
- Many practitioners who got warnings were completely unaware they’d done anything wrong
- Some practitioners have had their merchant services accounts suspended; others have received threats of disciplinary action
- Anything clinicians post on their practice websites could be considered “commercial speech” by FTC, even if the intention is simply to educate patients
- Regulators may view any reference to “immune system support” on a practitioner’s website as a syllogism for an unlawful COVID claim
Since March, the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) have been aggressive in policing online language about COVID—and with good reason. Fraudulent products and false claims are rampant.
Unfortunately, many clinicians have also been targeted simply for posting about things like Vitamin C and D, zinc, immune support herbs, and other holistic modalities.
These days, it is easy to run afoul of the regulations…without even knowing it.
In this in-depth webinar, legal and regulatory experts—including an official from the FTC—will discuss the current regulatory situation, the unprecedented enforcement actions, and the key guidelines you need to stay safely within bounds as you promote your practice and communicate with your patient community.
PRESENTERS & PANELISTS
- Adina Matasaru, Matasaru Law, PC
- Laura Farr, Executive Director, American Association of Naturopathic Physicians
- Michael D. Levin, Founder, Health Business Strategies, LLC, Consultant
- Loren Israelsen, Executive Director, United Natural Products Alliance
- Rich Cleland, Ass’t Director, Bureau of Consumer Protection, Federal Trade Commission
- Alan Dumoff, JD, MSW,
- Marc S. Ullman, Rivkin Radler Attorneys at Law
- Ron Hoffman, MD, Medical Director, Hoffman Center, New York, NY
MODERATOR: Erik Goldman, Editor, Holistic Primary Care
In this webinar, you’ll learn about:
- The laws governing permissible language for prevention and treatment claims
- How FDA and FTC enforce these regulations
- The difference between lawful and unlawful practice marketing
- The consequences of a warning letter–and what to do if you get one
- How to stay within the regulatory boundaries, while still fulfilling your professional obligation to inform your patient community about emerging science